AK
Therapeutic Areas
Avinger Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lumivascular CTO Crossing Platform | Chronic Total Occlusions (CTO) in Coronary Vessels | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| Lumivascular CTO Crossing Platform | Chronic Total Occlusions (CTO) in Coronary Vessels | Pre-clinical |